LONN CH0013841017

Report

Delayed Swiss Exchange - 11:31 2022-08-17 am EDT
560.60	CHF		+0.39%

08/04	Merck KGaA profit gets boost from dollar, outweighing higher costs	RE
07/28	LONZA : Half-Year Alternative Performance Measures Report	PU
07/25	AlphaValue/Baader Europe Lifts Price Target on Lonza, Maintains Add Recommendation	MT

Summary

Quotes 5-day view Delayed Quote.

Delayed Swiss Exchange

08/11/2022	08/12/2022	08/15/2022	08/16/2022	08/17/2022	Date
584(c)	570.2(c)	569.6(c)	558.4(c)	560.6	Last
153 529	143 965	85 246	98 514	89 916	Volume
+2.49%	-2.36%	-0.11%	-1.97%	+0.39%	Change

More quotes

Estimated financial data (e)

Sales 2022	6 208 M 6 532 M 6 532 M
Net income 2022	1 037 M 1 091 M 1 091 M
Net cash position 2022	347 M 365 M 365 M
P/E ratio 2022	40,8x
Yield 2022	0,58%

Sales 2023	6 946 M 7 308 M 7 308 M
Net income 2023	1 263 M 1 329 M 1 329 M
Net cash position 2023	90,7 M 95,4 M 95,4 M
P/E ratio 2023	33,8x
Yield 2023	0,64%

Capitalization	41 427 M 43 587 M 43 587 M
EV / Sales 2022	6,62x
EV / Sales 2023	5,95x
Nbr of Employees	17 154
Free-Float	99,6%

More Financials

Company

Lonza Group AG is one of the world leaders of the development, production and marketing of chemical products. Net sales break down by family of products and services as follows: - bio-pharmaceuticals (49.9%): exclusive syntheses, microbiological fermentation products , mammalian cell cultures, etc.; - capsules and dosing solutions for biopharmaceuticals, drugs and nutrition products (22.3%). In addition, the group...

Sector

Biotechnology & Medical Research

Calendar

08/30

Roadshow - Day 1

More about the company

Ratings of Lonza Group AG

Trading Rating :

Investor Rating :

ESG Refinitiv :

More Ratings

All news about LONZA GROUP AG

08/04	Merck KGaA profit gets boost from dollar, outweighing higher costs	RE
07/28	LONZA : Half-Year Alternative Performance Measures Report	PU
07/25	AlphaValue/Baader Europe Lifts Price Target on Lonza, Maintains Add Recommendation	MT
07/22	TRANSCRIPT : Lonza Group AG, H1 2022 Earnings Call, Jul 22, 2022	CI
07/22	Lonza Group Profit Balloons 89% in H1 as Sales Rises 17%	MT
07/22	Lonza Confident on 2022 Goals as 1st Half Sales Book Healthy Rise	DJ
07/22	Lonza's H1 Attributable Profit Jumps With 17% Sales Growth, Confirms FY22 Outlook	MT
07/22	Lonza's first-half core EBITDA gains 16.5%	RE
07/22	LONZA : Half-Year Results Report	PU
07/22	LONZA : Half-Year Results Presentation	PU
07/22	Lonza Delivers Solid Performance in H1 2022 with 16.8% CER Sales Growth and 33.1% CORE ..	EQ
07/22	Lonza Group AG Reports Earnings Results for the Half Year Ended June 30, 2022	CI
07/22	Lonza Group AG Reconfirms Sales Guidance for the Years 2022 and 2024	CI
07/22	LONZA GROUP AG : Press Release	CO
07/22	LONZA GROUP AG : Half-year results	CO

More news

News in other languages on LONZA GROUP AG

08/16	Aktien Schweiz schließen etwas leichter - Straumann unter Druck
08/10	L'inflation à quitte ou double
08/10	AVIS D'ANALYSTES DU JOUR : Aperam, Evotec, Hugo Boss, Lonza, Prysmian, Genmab, Pets at Hom..
08/03	BOLSA DE MADRID : Para relajarse, tendrá que volver más tarde
08/03	Pour la détente, il faudra repasser

More news

Analyst Recommendations on LONZA GROUP AG

07/25	AlphaValue/Baader Europe Lifts Price Target on Lonza, Maintains Add Recommendation	MT
07/21	AlphaValue/Baader Europe Lifts Price Target on Lonza Group, Maintains Add Recommendatio..	MT
06/03	AlphaValue/Baader Europe Lifts Price Target on Lonza Group, Maintains Add Recommendatio..	MT

More recommendations

Provided by Scoopnest.com

Analysis

Lonza's first-half core EBITDA gains 16.5%